![Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha](https://static.seekingalpha.com/uploads/2020/5/28/49171940-15906981016117995_origin.jpg)
Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha
![Bio-Rad's CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing - Clinical Laboratory int. Bio-Rad's CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing - Clinical Laboratory int.](https://clinlabint.com/wp-content/uploads/sites/2/2023/02/CFX_Opus-Deepwell_Dx_Left-scaled.jpg)
Bio-Rad's CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing - Clinical Laboratory int.
![Bio-Rad extends range of anti-idiotypic antibodies for bioanalysis and drug monitoring - BioTechniques Bio-Rad extends range of anti-idiotypic antibodies for bioanalysis and drug monitoring - BioTechniques](https://www.biotechniques.com/wp-content/uploads/2022/07/Bio-Rad-PR-JUly-22.png)